Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117942) titled 'FDGL Dose-Finding Study for Diabetic Neuropathy' on Aug. 5.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Care Provider).

Primary Sponsor: Helwan University

Condition: Diabetic Neuropathy

Intervention: Drug: Fermented Deglycyrrhizinated Licorice (FDGL)

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: February 12, 2020

Target Sample Size: 485

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07117942

Published by HT Di...